Table 2

Results of the initial electrophysiological study and RFCA

Monomorphic VT (n = 14)PVCs triggering VF (n = 5)
QRS duration, ms185 ± 34141 ± 16
Tachycardia cycle length, ms430 ± 35
Aetiology of the arrhythmias
 Reentry, n13 (93%)0
 Entrainment mapping possible, n11 (79%)
 Non-reentrant focal firing, n1 (7%)5 (100%)
Purkinje-related arrhythmia, n4 (29%)5 (100%)
 Bundle-branch reentry, n1 (7%)
 Left posterior Purkinje reentry,9n2 (14%)
 Non-reentrant focal firing, n1 (7%)
Suppression of the arrhythmias, n12 (86%)5 (100%)
Monomorphic VT (n = 14)PVCs triggering VF (n = 5)
QRS duration, ms185 ± 34141 ± 16
Tachycardia cycle length, ms430 ± 35
Aetiology of the arrhythmias
 Reentry, n13 (93%)0
 Entrainment mapping possible, n11 (79%)
 Non-reentrant focal firing, n1 (7%)5 (100%)
Purkinje-related arrhythmia, n4 (29%)5 (100%)
 Bundle-branch reentry, n1 (7%)
 Left posterior Purkinje reentry,9n2 (14%)
 Non-reentrant focal firing, n1 (7%)
Suppression of the arrhythmias, n12 (86%)5 (100%)

PVC, premature ventricular conduction; RFCA, radiofrequency catheter ablation; VF, ventricular fibrillation; VT, ventricular tachycardia.

Table 2

Results of the initial electrophysiological study and RFCA

Monomorphic VT (n = 14)PVCs triggering VF (n = 5)
QRS duration, ms185 ± 34141 ± 16
Tachycardia cycle length, ms430 ± 35
Aetiology of the arrhythmias
 Reentry, n13 (93%)0
 Entrainment mapping possible, n11 (79%)
 Non-reentrant focal firing, n1 (7%)5 (100%)
Purkinje-related arrhythmia, n4 (29%)5 (100%)
 Bundle-branch reentry, n1 (7%)
 Left posterior Purkinje reentry,9n2 (14%)
 Non-reentrant focal firing, n1 (7%)
Suppression of the arrhythmias, n12 (86%)5 (100%)
Monomorphic VT (n = 14)PVCs triggering VF (n = 5)
QRS duration, ms185 ± 34141 ± 16
Tachycardia cycle length, ms430 ± 35
Aetiology of the arrhythmias
 Reentry, n13 (93%)0
 Entrainment mapping possible, n11 (79%)
 Non-reentrant focal firing, n1 (7%)5 (100%)
Purkinje-related arrhythmia, n4 (29%)5 (100%)
 Bundle-branch reentry, n1 (7%)
 Left posterior Purkinje reentry,9n2 (14%)
 Non-reentrant focal firing, n1 (7%)
Suppression of the arrhythmias, n12 (86%)5 (100%)

PVC, premature ventricular conduction; RFCA, radiofrequency catheter ablation; VF, ventricular fibrillation; VT, ventricular tachycardia.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close